Study Design. A retrospective analysis. Objective. To evaluate the long-term clinical and radiographic outcomes and to investigate who achieved the successful outcomes after lumbar total disc replacement (TDR) using ProDisc II. Summary of Background Data. There are few evidences regarding the long-term efficacy and safety of TDR. Furthermore, it has not been addressed which patients achieved good outcomes in long-term follow-up. Methods. Data at 1-, 2-, 5-, 7-year, and last follow-up were used for the analysis. According to the presence of combined pathologies, patients were categorized as groups A and B (presumed good and bad candidates, respectively). Clinical outcomes were evaluated using visual analog scale, Oswestry Disability Index, clinical success rate, and subjective satisfaction (four-point scale). Radiographic results included segmental range of motion. Results. Total study population was 54 patients with 69 segments with the average follow-up duration of 120.0 months. There were 39 patients in group A and 15 in group B. Visual analog scale and Oswestry Disability Index scores were improved significantly at all follow-up periods, reaching maximal improvement at the postoperative 2 years. Clinical success rate and satisfaction rate were significantly higher in group A (76.9% and 87.2%, respectively) than those in group B (40.0% and 60.0%, respectively) at the last follow-up. Five patients (9.3%) required revision fusion surgeries, and they are all in group B. The final segmental range of motion was well maintained in monosegmental TDR, but not in bisegmental TDR.
L
umbar total disc replacement (TDR) has been introduced as an alternative technique to fusion surgery for the treatment of the painful degenerative disc disease (DDD). Theoretically, TDR is an ideal treatment option because it can remove the pain generator, which is diseased disc, while it can allow the motion of the affected segment. Numerous clinical studies, including several prospective randomized controlled trials, have been performed and reported the successful clinical outcomes. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Despite these promising results, the current use of TDR has been much decreased ever since the great enthusiasm in the earlyto mid-2000s for a variety of reasons, which are the higher cost compared with the posterior fusion surgery and the fear of the late complication and reoperation risk. 12, 13 This might be because there are few available evidences regarding its long-term clinical efficacy and safety. Furthermore, to date, it has not been clearly addressed which patients resulted in good outcomes or not in long-term follow-up.
The purpose of this study was to evaluate the long-term clinical and radiographic outcomes along with longitudinal changes, and to investigate which patients achieved the successful outcomes after TDR using ProDisc II for the treatment of DDD.
MATERIALS AND METHODS

Patients
A total of 64 consecutive patients (81 segments) who underwent TDR using ProDisc II between March 2002 and February 2007 by two surgeons were evaluated retrospectively. Indication and surgical technique have been well described in the previous report. 6 All patients were followed up annually and were assessed using the same evaluation protocol at the every visit. Among them, the patients who were followed up for more than 5 years were included in the study. Ten of the 64 patients were excluded from the study due to the early dropout before postoperative 5-year (n ¼ 7) and incomplete clinical data acquisition (n ¼ 3), producing the total 54 patients with follow-up rate of 84.4%. During follow-up, five patients underwent revision fusion surgeries at the index segment or adjacent segment; the detailed reoperation data will be described in the result section. For these five patients, we adopted the last data just before the revision surgery for the assessment of clinical and radiographic results.
Clinical Evaluation
The clinical data were obtained using visual analog scale (VAS) for back pain and Oswestry Disability Index (ODI) by medical staff or research assistants who were not involved in the patient management at the outpatient's visit. The data preoperatively, at 1-year, 2-year, 5-year, and the last followup visits, were selected for the clinical evaluation. At the final follow-up, clinical success was assessed using FDA definition.
14 Clinical success was defined as !25% improvement of ODI score with no device failure, no major complication, and no neurologic deficit. Two additional questions were asked at the clinic (for 30 patients) or by telephone assessment (for 24 patients who already completed the outpatient-based evaluation): ''How satisfied are you with the result of your surgery?'' and ''How often do you take a medicine for the control of back pain?'' The answer to the first question was made using a four-point scale (very satisfied, satisfied, dissatisfied, and very dissatisfied), and the second question using a four-point scale (no need, sometimes, frequently, and all the time).
Patient Categorization
All patients were operated for the predominant axial back pain originated from presumed DDD. However, after the meticulous re-evaluation of the preoperative data, we found out a few combined pathologies besides DDD which might affect the result negatively. [15] [16] [17] These were the surgery at the adjacent level of fused segment, spondylolisthesis (<10% slippage), retrolisthesis, facet joint arthritis (grade 1 or 2 according to Weishaupt criteria 18 ), and lateral recess stenosis. The patients were categorized into two groups according to the presence of these findings. Patients who had none of these conditions were assigned as group A and those who had one of these conditions as group B.
Radiographic Evaluation
The plain radiographic data preoperatively, at 1 year, 2 year, 5 year, and the last follow-up visits, were selected for the radiographic evaluation. The segmental range of motion (ROM) on the dynamic flexion and extension view and L1-S1 lumbar lordosis (LL) on the standing radiograph was measured. Segmental ROM at L3-4 level was excluded from the evaluation because of a small number of operated L3-4 level (n ¼ 5).
Statistical Analysis
Statistical analysis was performed by professional medical statistician using SPSS software (version 21.0.0; SPSS Inc, Chicago, IL). Paired or independent t test was used to compare the preoperative and postoperative clinical and radiographic data and to identify the difference of clinical data between two groups at each designated time. Categorical values between two groups were compared by x 2 test. P values of less than 0.05 were set for significance.
RESULTS
Total study population consisted of 54 patients with 69 segments: 18 men and 36 women ( Table 1 ). The average age at the time of operation was 44.1 AE 8.5 years (range, 23-59). The mean follow-up duration was 120.0 AE 19.3 months (range, 61-144). Thirty-two of 54 patients (59.3%) were followed up for more than 10 years ( Figure 1 ). The monosegmental TDRs were performed for 39 patients at the levels L3-4 (n ¼ 3), L4-5 (n ¼ 20), L5-S1 (n ¼ 16), and 15 patients were operated bisegmentally at the levels L3-5 (n ¼ 2) and L4-S1 (n ¼ 13). When dividing the patients into two groups in terms of preoperative combined pathologies, there were 39 patients in group A and 15 in group B ( Table 1 ). The accompanying conditions in group B were surgery at the adjacent level of fused segment (n ¼ 2), spondylolisthesis (n ¼ 3), retrolisthesis (n ¼ 3), grade 1-2 facet joint arthritis (n ¼ 6), and lateral recess stenosis (n ¼ 1).
Clinical Outcomes
Total VAS scores decreased significantly at postoperative 1 year and 2 year, compared with preoperative VAS score (P < 0.001, respectively, Figure 2 ). Although total VAS scores increased until the last follow-up, they remained the significantly lower than the preoperative value (P < 0.001 for all). When patients are separated into groups A and B, VAS scores at each group showed a similar pattern as with total VAS scores. The VAS scores at the last followup were significantly higher than 2-year's value for total, group A, and group B (P < 0.001 for all). VAS scores of group B were significantly higher than those of group A at 2 years, 5 years, 7 years, and the last follow-up (P ¼ 0.039, P ¼ 0.046, P ¼ 0.018, and P ¼ 0.002, respectively). Looking into ODI score, its pattern resembled those of VAS score ( Figure 2 ). All postoperative ODI scores at any follow-up time were significantly lower than the baseline values for total, group A, and group B (P < 0.001 for all). Although there was significant increase in ODI scores between 2-year and last follow-up for total and group B patients (P ¼ 0.014, P ¼ 0.008, respectively), the increase in ODI scores of group A between 5-year and last follow-up was not significant (P ¼ 0.096). The significant differences in ODI score between groups A and B were shown at 7 years and the last follow-up (P ¼ 0.040, P ¼ 0.017, respectively).
Overall, there were 36 patients (66.7%) who were assumed to achieve clinical success according to the FDA criteria. The clinical success rate was significantly higher in group A than group B (30/39, 76.9% vs. 6/15, 40.0%, P ¼ 0.010). In terms of satisfaction question, 28 patients answered ''very satisfied,'' 15 ''satisfied,'' 10 ''dissatisfied,'' and 1 ''very dissatisfied.'' The overall satisfaction rate (''very satisfied'' þ ''satisfied'') was 72.9% ( Figure 3 ). Group A patients showed more satisfactory results than group B patients (34/39, 87.2% vs. 9/15, 60.0%, P ¼ 0.017). Regarding the second question about the need for pain medicine, 26 patients (48.1%) answered ''no need,'' 11 ''sometimes,'' 11 ''frequently,'' and 6 ''all the time.'' There was also significant difference of medication needs between groups A and B (P ¼ 0.022, Figure 4 ).
Radiographic Outcomes
In monosegmental TDR, the segmental ROM was significantly increased at 2 years (P < 0.001, P ¼ 0.040, respectively). Thereafter, the segmental ROM decreased until the last follow-up, but the last ROM was comparable to the preoperative ROM ( Figure 5 ). In case of bisegmental TDR, the segmental ROM increase was not observed. Moreover, the final ROM was shown to be lower than the preoperative ROM (P ¼ 0.011, P ¼ 0.039, respectively). Lumbar lordosis (LL) was increased and well maintained during all postoperative follow-up times for both monosegmental and bisegmental TDR (Figure 6 ). Only in monosegmental TDR, the final LL was shown to be higher than the preoperative LL (P ¼ 0.011).
Reoperation
Revision surgeries were performed for five patients (9.3%) at 6.5 AE 1.9 years after the index operation (Table 2) . At the time of operation, all these patients have suffered from disabling back pain despite full conservative treatment. All five patients were belonged to the group B, which is assumed as poor candidate group. Thus, the reoperation rate was significantly higher in group B than in group A (5/ 15 vs. 0/39, P < 0.001). The causes of reoperation and surgical methods are listed in Table 2 . TDR devices were left in situ during surgery in all cases ( Figure 7A-C) .
DISCUSSION
To date, the number of available studies that have addressed long-term outcome after TDR using ProDisc II is limited. 8, 15 Thus, the first aim of this study was to report the long-term clinical outcomes of Prodisc II TDR. From the overall standpoint, the lumbar TDR using ProDisc II seemed to meet with the favorable outcomes in an average 10-year follow-up, producing the clinical success rate of 66.7% and the subjective satisfaction rate of 72.9%. According to Park's study of 35 patients with 6-year follow-up, they reported that clinical success was achieved in 71.4%. 8 Siepe et al 15 published the clinical results of 181 patients with a mean follow-up of 7.4 years. In this study, all clinical outcome scores were improved maintained during the follow-up and the subjective satisfaction rate was 86.3%. Our clinical success rate and subjective satisfaction results were somewhat lower than these two previous studies. This can be reasonable considering our patients were followed up longer than the previous two studies. It is generally accepted notion that the longer follow-up duration is likely to compromise the clinical results. For example, Putzier et al 9 reported the success rate was only 54% at mean 17-year follow-up using Charité prosthesis.
In the present study, the total VAS and ODI scores decreased gradually, reaching the maximal improvement at the postoperative 2 years. Thereafter, the clinical scores showed a tendency to be slightly deteriorated until the last follow-up, while maintaining the significant improvements from baseline ( Figure 2 ). These timeline trends of clinical score are comparable to the previous long-term studies. 8, 15, 19 Tropiano et al 19 studied 55 patients of ProDisc I TDR with mean 8.7-year follow-up. They observed the significant improvement in the clinical scores at the final evaluation compared with baseline, and they also notified significant worsening of clinical scores at the final follow-up compared with the results at postoperative 1 and 2 years.
The indication and contraindication for lumbar TDR have been well documented on the previous studies. 1, 5, 16, 17, 20 Obviously, the ideal indication for TDR is DDD without other accompanying pathologies such as spinal stenosis, predominant radiculopathy, facet joint arthrosis, spondylolisthesis, segmental instability, etc. After the meticulous retrospective data review, we found out 15 patients (group B) who did not meet the ideal indication for TDR, implying that they had symptomatic DDD as well as the other accompanying pathologies. We acknowledge that we do not know exactly why lumbar TDR was chosen rather than the fusion surgery at that time. However, the indication for TDR at that time was broader than the current one as Bertagnoli and Kumar 21 suggested in 2002. It is certain that all accompanying lesions were not so severe as to require the fusion surgery. When analyzing the results according to groups A and B separately, VAS scores of group B were significantly higher than those of group A at 2-, 5-, 7-year, and last follow-up (Figure 2) . ODI scores showed a similar pattern with VAS changes, showing significant worse result in group B compared with group A at 7-year and last followup (Figure 2) . In terms of the clinical success rate, subjective satisfaction rate, and medication needs, group B showed less satisfactory results compared with group A. It may not be surprising that all clinical results of group B were inferior to those of group A in the present study because the patients of group B had the accompanying pathologies which are expected to affect the result negatively. When confined to the results of group A, all clinical outcomes such as VAS, ODI scores, clinical success rate, satisfaction rate, and medicine-consumption rate are quite promising even in the long-term follow-up. Therefore, we think it cannot be emphasized enough that the patient selection is the most important step for the best outcomes as the other authors insist. 7, 15, 22 At this time, it should be noted that there has been a concern about the ideal indication. Huang and Cammisa's group studied retrospectively 100 patients who were considered for TDR, but underwent other surgery of fusion (n ¼ 56) or nonfusion (n ¼ 44), to evaluate the prevalence of contraindication to TDR. 16 They noted that only 5% of patients were ideal candidates for TDR and 100% patients were not candidate for TDR in the fusion surgery group. Wong et al 17 conducted a similar study and reported that all 100 patients had at least one contraindication to TDR, in which most common lesions were facet arthrosis. These two studies suggest that there may be no isolated discogenic pain that is considered the ideal indication for TDR. These studies were performed using the non-TDR patients' data. Moreover, all patients in these studies underwent lumbar fusion or decompression-only surgery, rather than TDR. Thus, although they suggested the ideal indication for TDR was rare, their suggestions might be far from the real practice. For example, the patients who had spondylolisthesis, spinal stenosis, facet arthritis, etc., are included in their studies. We think that it is still unclear what the ideal indication for TDR is. In the present study, we aimed to present the unfavorable combined pathologies to avoid rather than the ideal indication.
The reoperation was required for five patients in this study ( Table 2 ). The reoperation rate was 9.3%, which is comparable to the previous results (3.3-16%). 7, 15, 23, 24 The reasons for reoperation were persistent low back pain with facet arthritis in three patients, suspicious instability at index level in one, and adjacent level problem in two. There were no device-related complications. It is notable that all reoperation patients belonged to group B. Again, this finding suggests that the strict patient selection is critical to defer the reoperation risk as well as to achieve the favorable clinical outcomes.
Segmental ROM was more well preserved in monosegmental TDR than in bisegmental TDR (Figure 4 ). The preoperative ROM was well maintained at the last follow-up in case of monosegmental L4-5 and L5-S1 TDR. However, if operated bisegmentally, the segmental ROM of L4-5 and L5-S1 level at the final follow-up was substantially decreased than preoperatively. This decrease of segmental ROM may be mainly due to the development of heterotopic ossification (HO) although the current study did not address the issue of HO. According to the long-term follow-up study of Charité by Putzier, they observed the total ankyloses in 23% of patients. 9 Park et al evaluated 82 segments of 65 patients with a mean follow-up duration of 45 months. 25 They found that HO developed in 30.5% of patients mostly within 24 months. However, the development of HO and consequent decreased segmental ROM were not correlated with the clinical outcomes in both studies. The LL was well maintained during the followup duration ( Figure 5 ). Although the monosegmental TDR was more capable to maintain LL than bisegmental TDR, the differences of LL at the preoperative and final follow-up were so small with a maximum increase of 3.78 that it hardly likely to affect the clinical outcomes.
We should address the several limitations of this study. First, the current study is limited by its retrospective nature. Second, the patient selection criteria should be mentioned. This study included 15 patients who were not good candidate for TDR. We acknowledge that our inclusion criteria were somewhat broad earlier because there had been great enthusiasm about lumbar TDR in the early 2000s. This issue was already discussed above. Finally, this study lacks the evaluation of the adjacent segment and facet joint of index level, both of which are the current major concerns for lumbar TDR especially in the long-term follow-up. It has been reported that the adjacent level degeneration was minimal and the progression of the facet joint was considerable in mid-term follow-up. 4, 26 But, there are no long-term evidences regarding these issues. The radiographic longterm follow-up study using computed tomography and magnetic resonance imaging is being performed now.
In conclusion, lumbar TDR using Prodisc II achieved the relatively successful outcomes with the clinical success rate of 76.9% and the satisfaction rate of 87.2% when the patients were presumed as good candidate for TDR. However, the patients who had the combined pathologies showed suboptimal results with high risk of the revision surgeries. Thus, the strict patient selection process is mandatory for the successful outcomes.
Key Points
The retrospective study was performed to evaluate the clinical and radiographic outcomes of lumbar TDR using Prodisc II for the treatment of DDD with a mean follow-up duration of 10 year. VAS and ODI scores were improved significantly at all follow-up periods, reaching maximal improvement around the postoperative 2 years. The patients who were considered good candidates showed more successful results compared with the presumed poor candidates. The strict patient selection process is mandatory for the successful outcomes.
